RCMI Coordinating Center (RCMI CC) Header Logo

Connection

George Perry to Estrogens

This is a "connection" page, showing publications George Perry has written about Estrogens.
Connection Strength

0.364
  1. Casadesus G, Rolston RK, Webber KM, Atwood CS, Bowen RL, Perry G, Smith MA. Menopause, estrogen, and gonadotropins in Alzheimer's disease. Adv Clin Chem. 2008; 45:139-53.
    View in: PubMed
    Score: 0.068
  2. Casadesus G, Garrett MR, Webber KM, Hartzler AW, Atwood CS, Perry G, Bowen RL, Smith MA. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease. Drugs R D. 2006; 7(3):187-93.
    View in: PubMed
    Score: 0.059
  3. Webber KM, Casadesus G, Marlatt MW, Perry G, Hamlin CR, Atwood CS, Bowen RL, Smith MA. Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis. Ann N Y Acad Sci. 2005 Jun; 1052:201-9.
    View in: PubMed
    Score: 0.057
  4. Webber KM, Bowen R, Casadesus G, Perry G, Atwood CS, Smith MA. Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection. Acta Neurobiol Exp (Wars). 2004; 64(1):113-8.
    View in: PubMed
    Score: 0.052
  5. Bianco NR, Perry G, Smith MA, Templeton DJ, Montano MM. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage. Mol Endocrinol. 2003 Jul; 17(7):1344-55.
    View in: PubMed
    Score: 0.049
  6. Messman RD, Contreras-Correa ZE, Paz HA, Perry G, Lemley CO. Vaginal bacterial community composition and concentrations of estradiol at the time of artificial insemination in Brangus heifers. J Anim Sci. 2020 Jun 01; 98(6).
    View in: PubMed
    Score: 0.040
  7. Casadesus G, Zhu X, Atwood CS, Webber KM, Perry G, Bowen RL, Smith MA. Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. Curr Drug Targets CNS Neurol Disord. 2004 Aug; 3(4):281-5.
    View in: PubMed
    Score: 0.013
  8. Smith MA, Perry G, Atwood CS, Bowen RL. Estrogen replacement and risk of Alzheimer disease. JAMA. 2003 Mar 05; 289(9):1100; author reply 1101-2.
    View in: PubMed
    Score: 0.012
  9. Bowen RL, Smith MA, Harris PL, Kubat Z, Martins RN, Castellani RJ, Perry G, Atwood CS. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002 Nov 01; 70(3):514-8.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support